Biocon Limited has informed the Exchange about Qualified Institutions Placement

QIP at a discountFund Raising View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹347.00

prior close

₹348.05

announcement price

After-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.2%-0.2% vs market

Pharmaceuticals peers, median of 148sector+0.5%+0.5% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Midcap 150 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-0.6

15m

-0.5

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+1.2-0.2+0.5+0.5

Next day

+1.3+1.7-0.3+0.2+1.1

+0.5+2.4-1.8+1.2-0.6

+1.3+2.9-1.7+1.9-0.6

+0.8+3.5-2.7+1.8-1.0

+2.1+3.9-1.8+2.2-0.2

+4.5+4.4+0.1+2.8+1.7

15d

+7.6+2.9+4.7+3.5+4.1

+13.8+4.6+9.2+5.6+8.2

+3.7+2.6+1.1+0.2+3.6

+4.3+3.6+0.7+1.8+2.5

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Biocon Limited has closed its Qualified Institutions Placement (QIP) on June 19, 2025, which opened on June 16, 2025. The company allocated 13,63,63,635 equity shares to eligible qualified institutional buyers at ₹330 per share, raising approximately ₹4,500 crore. The issue price was set at a discount of ₹10.20 (3%) to the floor price of ₹340.20 per share. The shares have a face value of ₹5 each, with the issue price including a premium of ₹325 per share. The Fund Raising Committee approved the closure, allocation, and confirmation note during a meeting held on June 19, 2025.

Likely market impact

Biocon has successfully raised around ₹4,500 crore through the QIP, strengthening its capital base. However, allotting shares at a 3% discount to the floor price means existing shareholders face some dilution at below-market reference levels, which may exert mild short-term pressure on the stock price.